Verona Pharma Plc Stock Today
| VRNA Stock | USD 16.10 0.30 1.83% |
Performance0 of 100
| Odds Of DistressLess than 24
|
Verona Pharma is trading at 16.10 as of the 19th of April 2024, a -1.83 percent decrease since the beginning of the trading day. The stock's open price was 16.4. Verona Pharma has about a 24 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Verona Pharma PLC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 27th of April 2017 | Category Healthcare | Classification Health Care |
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom. The company has 77.45 M outstanding shares of which 6.56 M shares are at this time shorted by private and institutional investors with about 15.5 trading days to cover. More on Verona Pharma PLC
Moving together with Verona Stock
| 0.68 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
| 0.69 | ME | 23Andme Holding | PairCorr |
| 0.72 | DMTK | DermTech Financial Report 2nd of May 2024 | PairCorr |
Moving against Verona Stock
| 0.64 | A | Agilent Technologies Financial Report 28th of May 2024 | PairCorr |
| 0.64 | YS | YS Biopharma Report 22nd of April 2024 | PairCorr |
| 0.57 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
| 0.56 | DNTH | Dianthus Therapeutics Symbol Change | PairCorr |
| 0.54 | DRRX | Durect Financial Report 13th of May 2024 | PairCorr |
| 0.5 | DSGN | Design Therapeutics Downward Rally | PairCorr |
| 0.44 | VINC | Vincerx Pharma Financial Report 9th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 14th of May 2024
Verona Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Verona Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Verona Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | David PharmD | |||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Pharmaceutical Products (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Jakarta Stock Exchange, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, Pharmaceutical Products, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Verona Pharma report their recommendations after researching Verona Pharma's financial statements, talking to executives and customers, or listening in on Verona Pharma's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Verona Pharma PLC. The Verona consensus assessment is calculated by taking the average forecast from all of the analysts covering Verona Pharma. | ||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key measurements obtained from Verona Pharma's financial statements, Verona Pharma PLC is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Verona Pharma PLC is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||
Verona Pharma's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Verona Pharma's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Verona Pharma's financial leverage. It provides some insight into what part of Verona Pharma's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Verona Pharma PLC (VRNA) is traded on NASDAQ Exchange in USA. It is located in 3 More London Riverside, London, United Kingdom, SE1 2RE and employs 79 people. Verona Pharma is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.25 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Verona Pharma's market, we take the total number of its shares issued and multiply it by Verona Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Verona Pharma PLC conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 77.45 M outstanding shares of which 6.56 M shares are at this time shorted by private and institutional investors with about 15.5 trading days to cover.
Verona Pharma PLC currently holds about 111.51 M in cash with (50.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.83.
Check Verona Pharma Probability Of Bankruptcy
Ownership AllocationVerona Pharma maintains a total of 77.45 Million outstanding shares. The majority of Verona Pharma PLC outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Verona Pharma to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Verona Pharma PLC. Please pay attention to any change in the institutional holdings of Verona Pharma PLC as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Verona Ownership Details
Verona Stock Price Odds Analysis
What are Verona Pharma's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Verona Pharma jumping above the current price in 90 days from now is about 80.63%. The Verona Pharma PLC probability density function shows the probability of Verona Pharma stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.1079. This entails Verona Pharma PLC market returns are sensitive to returns on the market. As the market goes up or down, Verona Pharma is expected to follow. Additionally, verona Pharma PLC has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Verona Pharma to move above the current price in 90 days from now is about 80.63 (This Verona Pharma PLC probability density function shows the probability of Verona Stock to fall within a particular range of prices over 90 days) .
Verona Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Verona Pharma that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Verona Pharma's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Verona Pharma's value.| Instituion | Recorded On | Shares | |
| Hhg Plc | 2023-12-31 | 1.8 M | |
| Maverick Capital Ltd | 2023-12-31 | 1.7 M | |
| Jennison Associates Llc | 2023-12-31 | 1.6 M | |
| Eventide Asset Management, Llc | 2023-12-31 | 1.4 M | |
| First Turn Management Llc | 2023-12-31 | 1.2 M | |
| Aisling Capital Management Lp | 2023-12-31 | 1.1 M | |
| Hood River Capital Management Llc | 2023-12-31 | 946.6 K | |
| Bellevue Group Ag | 2023-12-31 | 840 K | |
| Avidity Partners Management Lp | 2023-12-31 | 780.9 K | |
| Ra Capital Management, Llc | 2023-12-31 | 6.3 M | |
| Nea Management Company, Llc | 2023-12-31 | 5.1 M |
Verona Pharma Historical Income Statement
Verona Pharma PLC Income Statement is one of the three primary financial statements used for reporting Verona's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Verona Pharma PLC revenue and expense. Verona Pharma Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Verona Pharma's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 45.9 M, whereas Operating Income is projected to grow to (64.4 M). View More FundamentalsVerona Stock Against Markets
Picking the right benchmark for Verona Pharma stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Verona Pharma stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Verona Pharma is critical whether you are bullish or bearish towards Verona Pharma PLC at a given time. Please also check how Verona Pharma's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Verona Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Verona Pharma Corporate Directors
Verona Pharma corporate directors refer to members of a Verona Pharma board of directors. The board of directors generally takes responsibility for the Verona Pharma's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Verona Pharma's board members must vote for the resolution. The Verona Pharma board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Vikas Sinha | Non-Executive Director | Profile | |
| Kenneth Cunningham | Non-Executive Director | Profile | |
| Anders Ullman | Non-Executive Director | Profile | |
| Martin Edwards | Independent Non-Executive Director | Profile |
How to buy Verona Stock?
Before investing in Verona Pharma, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Verona Pharma. To buy Verona Pharma stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Verona Pharma. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Verona Pharma stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Verona Pharma PLC stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Verona Pharma PLC stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Verona Pharma PLC, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Verona Stock please use our How to Invest in Verona Pharma guide.
Already Invested in Verona Pharma PLC?
The danger of trading Verona Pharma PLC is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Verona Pharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Verona Pharma. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Verona Pharma PLC is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Verona Pharma PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Verona Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Verona Pharma Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Verona Pharma Plc Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verona Pharma PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Verona Stock analysis
When running Verona Pharma's price analysis, check to measure Verona Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verona Pharma is operating at the current time. Most of Verona Pharma's value examination focuses on studying past and present price action to predict the probability of Verona Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verona Pharma's price. Additionally, you may evaluate how the addition of Verona Pharma to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
Is Verona Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verona Pharma. If investors know Verona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verona Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.72) | Revenue Per Share 0.006 | Return On Assets (0.15) | Return On Equity (0.23) |
The market value of Verona Pharma PLC is measured differently than its book value, which is the value of Verona that is recorded on the company's balance sheet. Investors also form their own opinion of Verona Pharma's value that differs from its market value or its book value, called intrinsic value, which is Verona Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verona Pharma's market value can be influenced by many factors that don't directly affect Verona Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verona Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verona Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verona Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.